Altus completes Phase I study of recombinant human growth hormone - TradingMarkets.com

by Hgh @ Sun, 25 Jan 2009 02:00:03 -0600
ALTU-238 is being developed as a subcutaneously administered, long acting formulation of recombinant human growth that employs Altus's proprietary protein crystallization and formulation technology, for patients with growth hormone ...
  • Recent posts